Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
In patients with cardiovascular disease, those with polyvascular disease are the most likely to progress to end-stage kidney disease, a study found. Patients with cardiovascular disease (CVD) are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback